Showing 2,781 - 2,800 results of 2,913 for search '"chest pain"', query time: 0.15s Refine Results
  1. 2781

    Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multi... by Yu Wei Zhao, Song Liu, Hao Qin, Jin Bo Sun, Mao Su, Guang Ji Yu, Jun Zhou, Fei Gao, Ruo Yu Wang, Tong Zhao, Guang Sheng Zhao

    Published 2023-04-01
    “…The main adverse reaction after DEB-BACE was chest pain (13/43, grade 1) followed by fever (10/43, grade 1–2), which was significantly relieved within 3–5 days after symptomatic treatment. …”
    Get full text
    Article
  2. 2782

    Association between glycated hemoglobin (HbA1c) level and cardiac perfusion and function on gated myocardial perfusion SPECT by Hatem Nasr, Hoda Alsomali, Ibrahim Saad, Asmaa AbdElaal, Nsreen Mohamadien

    Published 2023-05-01
    “…Patients with HbA1c% > 6.5 compared to ≤ 6.5%, had lower LVEF% of 53.17 ± 14.55 vs. 57.8 ± 12.61 (p = 0.017), lower HDL of 1.046 ± 0.262 vs. 1.196 ± 0.295 (p < 0.001), more LVEF < 50% (30% vs. 15.6%; p = 0.017), ESV > 44 ml (38.2% vs. 20%; p = 0.005), and WMA (24.5% vs. 12.2%; p = 0.027), hypertension (77.3% vs. 54.4%; p = 0.001) and dyspnea (27.3% vs. 15.6%; p = 0.047), however, with less chest pain (70.9% vs. 83.3%; p = 0.039). Diabetic patients with HbA1c% > 7.5 had lower LVEF% (52.0 ± 14.59 vs. 57.6 ± 11.55; p = 0.018) and HDL (1.005 ± 0.239 vs 1.148 ± 0.273; p < 0.002), more LVEF < 50% (33.3% vs. 14.5%; p = 0.011), ESV > 44 ml (41.3% vs. 20.3%; p = 0.009), WMA (30.2% vs. 11.6%; p = 0.008), and EDV > 100 ml (34.9% vs. 18.8%; p = 0.037). …”
    Get full text
    Article
  3. 2783
  4. 2784

    Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study by Lane, JCE, Weaver, J, Kostka, K, Burn, E, Kolovos, S, Prats-Uribe, A, Xie, J, Newby, D, Prieto-Alhambra, D, OHDSI-COVID-19 consortium

    Published 2020
    “…Addition of azithromycin appeared to be associated with an increased risk of 30-day cardiovascular mortality (calibrated HR 2·19 [95% CI 1·22–3·95]), chest pain or angina (1·15 [1·05–1·26]), and heart failure (1·22 [1·02–1·45]).…”
    Journal article
  5. 2785

    Esophageal variceal ligation plus sclerotherapy vs. ligation alone for the treatment of esophageal varices by Xiaofen Yue, Xiaofen Yue, Zeyu Wang, Jianbiao Li, Xiaoling Guo, Xiehua Zhang, Shengnan Li, Shengnan Li, Hongcheng Lv, Dongsheng Hu, Xiangjun Ji, Shuang Li, Wei Lu

    Published 2022-10-01
    “…The adverse events (fever, chest pain, swallowing, and esophageal stricture) showed no significant difference between the two groups (P &gt; 0.05). …”
    Get full text
    Article
  6. 2786

    Patterns and Outcomes of Obesity Using Body Mass Index in Patients Hospitalized with Acute Cardiovascular Disorders: A Retrospective Analysis of 7284 Patients in a Middle Eastern C... by Abdul Rehman Abid, Ayman El-Menyar, Rajvir Singh, Mohamed Gomaa, Said Habib, Ahmed Shaaban Abdelrahman, Nidal Asaad, Awad AlQahtani, Hassan Al-Thani, Hajar AlBinali, Jassim Al Suwaidi

    Published 2023-11-01
    “…Diabetes mellitus (DM), hypertension, and dyslipidemia were more common in Group III. Chest pain was more common in Group II, while shortness of breath was more evident in Group III (<i>p</i> < 0.001). …”
    Get full text
    Article
  7. 2787

    Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study by Chengjie Ma, Bojun Chen, Yanming Li, Li Gu, Jianping Dong, Zhenyang Xu, Lijuan Wei, Zhihong He, Xiuhong Nie, Shuwen Feng, Bin Cao, Lei Sun, Limin Yang, Xingwang Li, Rongmeng Jiang

    Published 2024-01-01
    “…There were no statistical differences in fever, sputum color change, chest pain, muscle pain, dyspnea, chills, and thirst between the two groups (p &gt; 0.05).SafetyThere were no significant differences in body weight, vital signs, blood routine, urine routine, stool routine, and blood biochemical indicators (CK, AST, ALT, Cr, and Bun) between the two groups before and after treatment (p &gt; 0.05). …”
    Get full text
    Article
  8. 2788

    Coronary fistula between left anterior descendent artery and pulmonary artery: Case report with literature review by Rafael Figueroa-Casanova, Juan D. Saavedra-Henao, Monica B. Mosos-Patiño, Nicolas Lozano-Suarez, Diego A. Beltran-Rincon, Carlos J. Perez-Rivera

    Published 2023-01-01
    “…Their clinical presentation is commonly asymptomatic, and is mainly found as an incidental diagnosis in coronary angiography or coronary angioTAC.We report a young adult without comorbidities who presented with chest pain. Biomarker elevation was confirmed, and acute coronary syndrome was suspected. …”
    Get full text
    Article
  9. 2789

    Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy by Abuduaini B, Yang L, Jiamali N, Seyiti Z, Shan XF, Gao XM

    Published 2023-04-01
    “…The TyG index was calculated using the [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2] equation.Results: After adjusting for age, BMI, and other potential confounders, the scores of multivariate Cox proportional hazards regression models for chest pain [9.056 (4.370 to 18.767), p< 0.001], acute myocardial infarction [4.437 (1.420 to 13.869), p=0.010], heart failure [7.334 (3.424 to 15.708), p< 0.001], cardiogenic shock [3.707 (1.207 to 11.384), p=0.022], malignant arrhythmia [5.309 (2.367 to 11.908), p< 0.001], cerebral infarction [3.127 (1.596 to 6.128), p< 0.001], gastrointestinal bleeding [4.326 (1.612 to 11.613), p=0.004], all-cause death [4.502 (3.478 to 5.827), p< 0.001] and cumulative incidence of MACCEs [4.856 (3.842 to 6.136), p< 0.001] increased significantly with an increase in TyG index levels (all p< 0.05). …”
    Get full text
    Article
  10. 2790

    Clinical impact of cardiac magnetic resonance in patients with suspected coronary artery disease associated with chronic kidney disease (AQUAMARINE-CKD study): study protocol for a... by Teruo Noguchi, Hideki Ota, Naoya Matsumoto, Yoshiaki Morita, Akira Oshita, Eiji Kawasaki, Tomohiro Kawasaki, Kensuke Moriwaki, Shingo Kato, Kazuki Fukui, Tomoya Hoshi, Hiroaki Watabe, Tomoaki Kanaya, Yasuhide Asaumi, Yu Kataoka, Fumiyuki Otsuka, Kensuke Takagi, Shuichi Yoneda, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Hiroyuki Miura, Kunihiro Nishimura, Kei Takase

    Published 2022-10-01
    “…Abstract Background Although screening for coronary artery disease (CAD) using computed tomography coronary angiography in patients with stable chest pain has been reported to be beneficial, patients with chronic kidney disease (CKD) might have limited benefit due to complications of contrast agent nephropathy and decreased diagnostic accuracy as a result of coronary artery calcifications. …”
    Get full text
    Article
  11. 2791

    Overruling of Procalcitonin-Guided Antibiotics for Lower Respiratory Tract Infections in Primary Care: Ancillary Study of a Randomized Controlled Trial by José Knüsli, Loïc Lhopitallier, Andreas Kronenberg, Jean-Yves Meuwly, Onya Opota, Marc-Antoine Perrenoud, Marie-Anne Page, Kevin C. Kain, Aline Mamin, Valérie D’Acremont, Nicolas Senn, Yolanda Mueller, Isabella Locatelli, Noémie Boillat-Blanco

    Published 2023-02-01
    “…Factors associated with an overruling of procalcitonin guidance were: a history of chest pain (adjusted OR [aOR] 1.81, 95% confidence interval 1.03–3.17); a prescription of chest X-ray by the GP (aOR 4.65, 2.32–9.34); a C-reactive protein measured retrospectively above 100 mg/L (aOR 7.48, 2.34–23.93, reference ≤ 20 mg/L); the location of the GP practice in an urban setting (aOR 2.27, 1.18–4.37); and the GP’s number of years of experience (aOR per year 1.05, 1.01–1.09). …”
    Get full text
    Article
  12. 2792

    The Association Between Intradialytic Symptom Clusters and Recovery Time in Patients Undergoing Maintenance Hemodialysis: An Exploratory Analysis by Arrti A. Bhasin, Jennifer M. MacRae, Braden Manns, Kelvin C. W. Leung, Amber O. Molnar, Jason W. Busse, David Collister, K Scott Brimble, Christian G. Rabbat, Jessica Tyrwhitt, Andrea Mazzetti, Michael Walsh

    Published 2024-03-01
    “…The second cluster included nausea/vomiting, diarrhea and chest pain, and headache. The first cluster (median score: −0.56, 25th to 75th percentile: −1.18 to 0.55) was independently associated with longer recovery time (odds ratio [OR] 1.62 per unit difference in score, 95% confidence interval [CI]: 1.23-2.12) and decreased PCS (−0.72 per unit difference in score, 95% CI: −1.29 to −0.15) and MCS scores (−0.82 per unit difference in score, 95% CI: −1.48 to −0.16), whereas the second cluster was not (OR 1.24, 95% CI: 0.97-1.58; PCS 0.19, 95% CI −0.46 to 0.83; MCS −0.72, 95% CI: −1.50 to 0.06). …”
    Get full text
    Article
  13. 2793

    ‘Grey nomad’ travellers’ use of remote health services in Australia: a qualitative enquiry of hospital managers’ perspectives by Margaret Yates, Lin Perry, Jenny Onyx, Tracy Levett-Jones

    Published 2022-02-01
    “…Traveller presentations were described as predominantly exacerbations of chronic illness such as chest pain, medication-related attendances, and accidents and injuries. …”
    Get full text
    Article
  14. 2794

    Efeitos cardiovasculares da anestesia local com vasoconstritor durante exodontia em coronariopatas Cardiovascular effects of local anesthesia with vasoconstrictor during dental ext... by Valeria C. L. S. Conrado, Januário de Andrade, Gabriella A. M. C. de Angelis, Ana Carolina P. de Andrade, Lilia Timerman, Mercedes M. Andrade, Dalmo R. Moreira, Amanda G. M. R. Sousa, J. Eduardo M. R. Sousa, Leopoldo S. Piegas

    Published 2007-05-01
    “…RESULTS: Three patients in group I presented ST-segment depression (1.0 mm) during administration of anesthesia; two other patients in group I had CK-MB mass elevation, and ischemia was not observed in any other case, as assessed by the other methods. No chest pain, arrhythmias, occurrence or worsening of left ventricular segmental hypocontractility or mitral regurgitation were observed in the study. …”
    Get full text
    Article
  15. 2795
  16. 2796
  17. 2797
  18. 2798

    Pregnancy-Associated Spontaneous Coronary Acute Dissection as a Cause of Sudden Cardiac Death—Autopsy Findings and Literature Review: Is COVID-19 Related? by Timur Hogea, Bogdan Andrei Suciu, Laura Chinezu, Klara Brinzaniuc, Emil Marian Arbănași, Ancuța Ungureanu, Réka Kaller, Cosmin Carașca, Eliza Mihaela Arbănași, Vlad Vunvulea, Ioana Hălmaciu, Adrian Vasile Mureșan, Eliza Russu, Claudiu Constantin Ciucanu, Casandra Maria Radu, Carmen Corina Radu

    Published 2023-07-01
    “…This present study reports two cases over 35 years, one being infected with SARS-COV2 one month before the event and the other being tested positive during admission, both asymptomatic, who were declared healthy on periodic clinical evaluations, with pregnancies over 35 weeks, with normal fetal development, which suddenly caused chest pain, dyspnea, and loss of consciousness, required emergency c-sections, and died suddenly after they were performed. …”
    Get full text
    Article
  19. 2799

    The utility of cardiopulmonary exercise testing in athletes and physically active individuals with or without persistent symptoms after COVID-19 by Gisele Mendes Brito, Danilo Marcelo Leite do Prado, Diego Augusto Rezende, Luciana Diniz Nagem Janot de Matos, Irineu Loturco, Irineu Loturco, Marcelo Luiz Campos Vieira, Ana Lúcia de Sá Pinto, Rodrigo Otávio Bougleux Alô, Lorena Christine Araújo de Albuquerque, Flavia Riva Bianchini, Ana Jéssica Pinto, Hamilton Roschel, Ítalo Ribeiro Lemes, Bruno Gualano, Coalition SPORT-COVID-19

    Published 2023-04-01
    “…Persistent symptoms were defined as fatigue, dyspnea, chest pain, dizziness, tachycardia, and exertional intolerance persisting &gt;2 months after COVID-19 diagnosis.ResultsA total of 46 participants were included; sixteen (34.8%) were asymptomatic and thirty participants (65.2%) reported persistent symptoms, with fatigue and dyspnea being the most reported ones (43.5 and 28.1%). …”
    Get full text
    Article
  20. 2800

    Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19 by Jitendra Kumar Chaudhary, Deepika Saini, Pankaj Kumar Chaudhary, Anurag Maurya, Ganesh Kumar Verma, Akhilesh Kumar Gupta, Rakesh Roshan, Tarun Kumar Vats, Nidhi Garg, Deepika Yadav, Nimita Kant, Anil Kumar Meena, Anissa Atif Mirza-Shariff

    Published 2022-07-01
    “…After an average incubation period of 2–14 days, the majority of infected individuals remain asymptomatic and/or mildly symptomatic, whereas the remaining individuals manifest a myriad of clinical symptoms, including fever, sore throat, dry cough, fatigue, chest pain, and breathlessness. SARS-CoV-2 exploits the angiotensin converting enzyme 2 (ACE-2) receptor for cellular invasion, and lungs are amongst the most adversely affected organs in the body. …”
    Get full text
    Article